BMS-577098 is an orally active and ATP-competitive insulin-like growth factor-1 receptor ( IGF-1R ) inhibitor with an IC 50 of 0.016 μM. BMS-577098 shows anti-tumor effect.
Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Signaling Pathways > IGF-1R
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.